Top News
Latest News
TECHNOLOGY
16 Aug 2026
Novo Nordisk Names AWS Its AI Partner for Drug Discovery
A new London hub pairs AWS cloud and AI tools with Novo Nordisk data to speed obesity drug research.
INSIGHTS
11 Aug 2026
UK Beats Europe to Approving Eli Lilly's Obesity Pill
MHRA clears Foundayo for weight loss as a NICE reimbursement decision looms in November.
INNOVATION
6 Aug 2026
Semaglutide's European Patent Cliff Isn't Here Yet
A Dutch court blocks a compounded nasal spray, showing Novo Nordisk's exclusivity runs to 2031.
PARTNERSHIPS
23 Jul 2026
Samsung Buys Swiss Peptide Maker for $1.8 Billion
Samsung Biologics acquires PolyPeptide Group to secure scarce manufacturing capacity for GLP-1 drugs.
MARKET TRENDS
17 Jul 2026
Novo's Oral Wegovy Beats Rival Pill to EU Approval
Novo Nordisk secures the first EU-wide clearance for an oral GLP-1, ahead of Eli Lilly's competing pill.
INVESTMENT
21 Jun 2026
A Danish Foundation Bets on Europe's Obesity Science
The Novo Nordisk Foundation commits 450m kroner to move cardiometabolic research out of the lab.
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.